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Abstract
Objective: To evaluate community-based values for avoiding pandemic influenza (A) H1N1 (pH1N1) illness and vaccination-
related adverse events in adults and children.
Methods: Adult community members were randomly selected from a nationally representative research panel to complete
an internet survey (response rate=65%; n=718). Respondents answered a series of time trade-off questions to value four
hypothetical health state scenarios for varying ages (1, 8, 35, or 70 years): uncomplicated pH1N1 illness, pH1N1 illness-
related hospitalization, severe allergic reaction to the pH1N1 vaccine, and Guillain-Barre ´ syndrome. We calculated
descriptive statistics for time trade-off amounts and derived quality adjusted life year losses for these events. Multivariate
regression analyses evaluated the effect of scenario age, as well as respondent socio-demographic and health characteristics
on time trade-off amounts.
Results: Respondents were willing to trade more time to avoid the more severe outcomes, hospitalization and Guillain-Barre ´
syndrome. In our adjusted and unadjusted analyses, age of the patient in the scenario was significantly associated with time
trade-off amounts (p-value,0.05), with respondents willing to trade more time to prevent outcomes in children versus
adults. Persons who had received the pH1N1 vaccination were willing to trade significantly more time to avoid
hospitalization, severe allergic reaction, and Guillain-Barre ´ syndrome, controlling for other variables in adjusted analyses.(p-
value,0.05)
Conclusions: Community members placed the highest value on preventing outcomes in children, compared with adults,
and the time trade-off values reported were consistent with the severity of the outcomes presented. Considering these
public values along with other decision-making factors may help policy makers improve the allocation of pandemic vaccine
resources.
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Introduction
In April 2009, the first influenza pandemic in over forty years
began in North America; the causative virus was 2009 pandemic
influenza (A) H1N1 (pH1N1). Under guidance from the Advisory
Committee for Immunization Practices (ACIP), the Centers for
Disease Control and Prevention recommended target groups for
vaccination [1]. A vaccine became available during October 2009,
and a program was implemented on an emergency basis to reduce
the impact of the expanding pandemic.
Vaccination programs, such as the one implemented for
pH1N1, involve an inherent trade-off of risks. Vaccinating for a
particular disease reduces the risk of infectious illness, but
introduces new risks of vaccine-related adverse events. The
acceptability of a vaccination program depends in part on how
the public values the potential risks and benefits of vaccination. By
examining the likelihood of these risks and benefits, as well the
value of prevention, decision makers can determine the potential
value of a public vaccination program. When pH1N1 vaccine
recommendations were made in the U.S. the only studies
reporting community values associated with influenza illness and
vaccination were based on data from seasonal influenza [2,3,4].
Outcomes related to pH1N1 illness and vaccination may be
valued differently, however. We present in this study estimates of
community-based values for avoiding adult and pediatric health
events related to pH1N1 illness and vaccination.
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Ethics Statement
This study was reviewed and provided with exempt status by the
University of Michigan institutional review board. All study data
were de-identified; no informed consent was required by the board
in order for individuals to participate in the study.
Overview
We used the time trade off (TTO) approach to evaluate
community-based values for avoiding pH1N1 illness and vaccina-
tion-related adverse events in adults and children. The TTO
method estimates the value each respondent puts on avoiding a
particular health outcome by estimating their willingness to trade
quantity of life for quality of life. For example, a TTO question
may value diabetes prevention by measuring the amount of time a
person would be willing to give up from her life span to avoid
living with diabetes (living instead a reduced number of years
without diabetes). The resulting TTO values can be interpreted as
subjective measures of quality of life, and are the basis for
constructing quality adjusted life years (QALYs). QALYs are
created by weighting a segment of time spent in a specific health
state by the quality of life value associated with that health state.
QALYs have been used to measure the morbidity associated with
chronic illness over an extended time period [5]. In our study, to
value the morbidity associated with the health states of pH1N1
illness and vaccination-related adverse events, we used TTO
responses from our survey to calculate short-term QALY losses.
Study participants
We randomly sampled adult community members to complete
an internet survey from a research panel designed to be statistically
representative of the U.S. general adult population. The survey
was administered by Knowledge Networks (Menlo Park, CA),
which currently recruits new research panel members by mail
from a published address-based sample frame that covers
approximately 98% of U.S. households [6]. Non-internet
households who choose to join the panel are provided with
internet access and a laptop computer. Households who use their
own computer and internet service to answer online surveys
administered by Knowledge Networks receive small monthly
stipends in exchange for their participation [7]. Demographic
information collected for all new panel members includes gender,
age, ages of their household members, race/ethnicity, income, and
education level.
Study Procedures
Participation in the study required completion of a 15-minute
survey during January 2010. Respondents answered a series of
TTO questions to value hypothetical health state scenarios
describing: uncomplicated pH1N1 illness, pH1N1 illness-related
hospitalization, severe allergic reaction to the pH1N1 vaccine, and
Guillain-Barre ´ syndrome, a potential vaccine-related adverse
event. Each of the 4 health state scenarios had 4 versions; each
referencing a hypothetical person aged 1, 8, 35, and 70 years.
Respondents were randomly assigned to value 2 different ages for
each of the 4 scenarios, for a total of 8 TTO questions. The
different age versions of each health state scenario were identical
except for the description of usual activities, which included
school/daycare for children and work/household responsibilities
for adults. We instructed respondents to imagine a family member
or friend that closely matched the age description in the scenario
at hand. Respondents were also asked whether they had been
vaccinated for pH1N1 or seasonal influenza, and whether they or
anyone else in their family had ever experienced pH1N1 or
seasonal influenza illness or an influenza vaccination-related
adverse event.
TTO estimation
We used a modified bidding algorithm, combining binary and
open ended response questions, to measure TTO amounts. This
method is less prone to non-response problems compared to a
single open ended question [8]. After presenting one age-specific
health event related to pH1N1 illness or vaccination, we first asked
respondents whether they would trade a fixed amount of time
from the end of their life in exchange for avoiding the health event.
(Figure 1) The amount of time that the respondents were asked to
trade was randomized to reduce anchoring bias, with initial TTO
amounts ranging from 2 days to 2 months for uncomplicated flu
and severe allergic reaction outcomes, and 2 weeks to 1 year for
hospitalization and Guillain-Barre ´ syndrome outcomes. A follow
up binary question offered a higher TTO amount if the initial
response was ‘‘yes,’’ and a lower TTO amount if the initial
response was ‘‘no.’’ These two binary questions were followed by
an open-ended question which asked respondents for the
maximum amount of time they would trade from the end of their
life (in days, weeks, months, and years) to avoid the health state in
question; this maximum TTO value was used for all analyses.
Analyses
We calculated descriptive statistics for TTO data, including
means, medians, 5
th and 95
th percentiles, minimums and
maximums. Confidence intervals around mean values were
estimated using bootstrapping with replacement procedures [9].
We used the Kruskal-Wallis non-parametric test in unadjusted
analyses to evaluate whether median values differed by scenario
age. All summary statistics used unweighted data, due to the
similarity between unweighted and weighted summary statistics. In
our primary analysis, TTO amounts greater than life expectancy
were reset to equal the respondent’s life expectancy, and we
evaluated the effect of this in sensitivity analyses.
As respondents were asked their willingness to trade time from
the end of their life, we adjusted for the potential impact of time
preference by using a 3% discount rate to calculate discounted
TTO values [5,10]. Dividing the respondents’ discounted TTO
amount by their discounted life expectancy allowed us to calculate
a short term QALY loss associated with the temporary health state
in question.
To evaluate the association between TTO amounts and
respondent/scenario characteristics, we used a generalized
estimating equation negative binomial regression model. This
type of regression model is bounded at 0 to account for the lower
limit of TTO responses and adjusts for the correlations associated
with multiple evaluations per respondent [11]. Using the
undiscounted TTO amounts reported for the four different health
states as the dependent variables, the four final regression models
each included as independent variables: scenario age, gender,
respondent age, education, race/ethnicity, having a child under
the age of 18, vaccination status, and experience with the health
state in question. The goodness of fit of each model was measured
using a test of concordance between the observed and predicted
TTO values [12].
Results
Respondents
The survey was sent to 1,110 members of the survey panel. Of
those invited by email to participate in the online survey, 65%
Public Values for H1N1 Outcomes
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e27777completed the survey (n=718); 9% of respondents were
eliminated from the primary analysis due to missing or invalid
responses, leaving a final analysis sample size of n=659.
Observations were excluded from the analysis if TTO amounts
were missing for more than half (4 or more) of the scenarios
(n=56), the responses in all four time metrics were equivalent
(n=2), or the TTO amount was nonsensical (e.g., 999999 months)
(n=1).
Demographic characteristics among those who responded to the
survey were statistically different from those who did not respond
to the survey for all demographic characteristics except location
(country region and metropolitan status). Compared to non-
responders, responders were more likely to be male, white,
married, aged 45 or older, college educated, and earn more than
$35,000 annually; respondents were also less likely to have a child
under the age of 18 years. (p,0.05 for all)
Respondent characteristics included in the primary analysis are
summarized in Tables 1, and 2. Without survey weights, 50% of
respondents were male, 56% were married, 78% were white, non-
Hispanic, 33% had a child under the age of 18 living at home, and
84% rated themselves in excellent/very good or good overall
health. Forty two percent of all respondents had received the
seasonal flu vaccine in the previous 12 months, and 21% had
received the pH1N1 vaccine in this time period. Thirty one
percent of respondents reported that they had experienced
seasonal influenza themselves, and 18% had a family member
who had experienced this illness at some point in the past. Three
percent of respondents had experienced pH1N1 illness themselves,
and 5% had a family member who had experienced this illness.
Only a small fraction of respondents (,1–2%, depending on
question) reported that they had experienced a hospitalization
related to influenza, or a side effect from an influenza vaccine,
either personally or through a family member.
Descriptive statistics
Respondents were willing to trade a median of 7 undiscounted
days to avoid a hospitalization related to pH1N1 influenza and
30 days to avoid Guillain-Barre ´ syndrome, compared to a
median of 2 and 4 undiscounted days to avoid uncomplicated
pH1N1 illness and severe allergic reaction, respectively (Table 3).
Due to the right skewed distribution for TTO amounts in all 4
health states (unsymmetrical, with the greatest proportion of
respondents willing to trade 0 days), mean values were
substantially higher and more variable than median values.
Figure 1. Time trade off question with sample health scenarios.
doi:10.1371/journal.pone.0027777.g001
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undiscounted days to avoid a hospitalization and Guillain-Barre ´
syndrome, and a mean of 226 and 222 undiscounted days to
avoid uncomplicated pH1N1 illness and a severe allergic
reaction, respectively. (Table 3)
When stratified by scenario age within each health state,
median TTO amounts differed significantly by age (p-value,0.05
for all health states). (Table 3) On average, respondents were
willing to trade more time to avoid pH1N1-related illnesses and
vaccination-related adverse events in children, compared to adults.
Respondents were willing to trade a median of 3 and 14
undiscounted days to avoid pH1N1 illness and hospitalization in
a 1 year old child, but were only willing to trade a median of 2 and
7 days to avoid these same outcomes in a 70 year old adult.
Likewise, respondents were willing to trade a median of 7 and 60
undiscounted days to prevent a severe vaccine allergic reaction
and Guillain-Barre ´ syndrome in a 1 year old child, but were only
willing to trade a median of 2 and 28 days, to avoid these same
outcomes in a 70 year old adult. (Table 3)
The median values for the loss in QALYs from pH1N1 illness
and vaccination-related adverse events also exhibited a significant
difference by scenario age (p-value,0.05 for all health states).
(Table 4) For example, pH1N1-related hospitalization was
associated with a 0.0007 median QALY loss for a 1 year old
and a 0.0003 median QALY loss for a 70 year old. Likewise,
Guillain-Barre ´ syndrome was associated with a 0.0039 median
QALY loss for a 1 year old and a 0.0012 median QALY loss for a
70 year old. Mean values were consistently higher and more
variable than median values. (Table 4)
Regression analyses
After adjusting for respondent characteristics, the 1 year and 8
year old scenario ages were significantly associated with greater
TTO amounts (compared with the 35 year old scenario age) in all
four final regression models. (p-values,0.05, Table 5) Seventy
year old scenario age was significantly associated with lower TTO
amounts (compared to the 35 year scenario age) in the final
regression models for hospitalization and Guillain-Barre ´ syndrome
outcomes.
For all four health states, having less than a college degree was
significantly associated with greater TTO amounts. (Table 5)
Other demographic characteristic associations were not consistent
across outcomes, however. Compared with a white, non-Hispanic
reference group, being Hispanic or black, non-Hispanic, was
significantly associated with greater TTO amounts for uncompli-
cated pH1N1 illness and allergic reaction only. Being over the age
of 30 was significantly associated with greater TTO amounts for
uncomplicated pH1N1 illness and Guillain-Barre ´ syndrome only.
Respondent health characteristic associations were also incon-
sistent predictors of TTO amounts. Experience with uncompli-
cated pH1N1 illness and Guillain-Barre ´ syndrome was signifi-
cantly associated with greater TTO amounts for those respective
health states, but experience with pH1N1-related hospitalization
and severe allergic reaction was not significantly associated with
the TTO amounts for these outcomes. Compared to respondents
that had not been vaccinated for pH1N1, those that had been
vaccinated were willing to trade significantly more time to avoid a
pH1N1-related hospitalization (p-value=0.03) but were also
willing to trade more time to avoid both vaccination related
adverse events. (p-value,0.05 for both)
Respondent’s gender, and having a child under 18, did not
significantly impact TTO responses. Concordance coefficients,
used to measure the goodness of fit of our models, ranged from
0.071 to 0.129. All coefficients were significantly greater than zero,
indicating that there was a significant and positive correlation
between our observed and predicted TTO values. (Table 5)
Sensitivity analyses which excluded respondents who traded
Table 1. Respondent demographic characteristics (n=659).
Frequency
Characteristic Unweighted Weighted
1
Gender
Male 49.9% 49.8%
Female 50.1% 50.2%
Age
18–29 15.9% 20.6%
30–44 24.4% 27.7%
45–59 33.9% 27.7%
60+ 25.8% 24.0%
Education
Less than High School 11.2% 12.4%
High School 33.6% 30.3%
Some College 26.4% 28.3%
Bachelor’s degree or higher 28.8% 29.0%
Race
White, Non-Hispanic 77.7% 70.4%
Black, Non-Hispanic 7.7% 10.4%
Other, Non-Hispanic 2.6% 5.4%
Hispanic 10.2% 12.7%
2+ races, Non-Hispanic 1.8% 1.1%
Marital Status
Married 55.5% 52.3%
Single (never married) 21.5% 23.3%
Divorced 11.1% 12.8%
Widowed 6.1% 5.0%
Separated 1.2% 2.0%
Living with partner 4.6% 4.6%
Household Income
,3 times poverty level 44.3% 43.2%
$3 times poverty level 45.4% 45.3%
Don’t Know 10.3% 11.5%
Regions
Northeast 19.3% 19.1%
Midwest 21.5% 20.4%
South 36.1% 37.8%
West 23.1% 22.7%
Global Health
Excellent/Very Good 47.6% 45.8%
Good 36.0% 38.1%
Fair 13.5% 13.4%
Poor 2.9% 2.7%
Child Under 18 Living at Home 32.5% 32.5%
TTO questions hard to answer 51.0% 51.4%
Households with Internet 62.2% 63.6%
1Post stratification weights were provided by Knowledge Networks to account
for sampling and non-response bias.
doi:10.1371/journal.pone.0027777.t001
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the primary analysis, which included these respondents with their
TTO amounts reset to their life expectancy (results not shown).
Discussion
This study reports community values for avoiding pH1N1
illness-related outcomes and vaccination-related adverse events in
the U.S. On average, respondents’ values for avoiding pH1N1-
related health events and vaccination-related adverse events were
aligned with the portrayed severity of these events in our survey.
Compared to pH1N1 illness-related hospitalization, respondents
were willing to trade less time to avoid uncomplicated pH1N1
illness and a severe allergic reaction from vaccination, across all
scenario ages. Respondents were willing to trade the greatest
amount of time to avoid the most severe outcome, Guillain-Barre ´
syndrome. This relative ranking of these TTO values across
outcomes is consistent with previous findings for outcomes
associated with seasonal influenza illness and vaccine related
adverse events [3]. In regression analyses, 1 year and 8 year old
scenario ages were consistently associated with greater TTO
amounts, indicating that the public may give preference to
preventing pH1N1 illness and vaccine- related health outcomes in
children compared with adults. These data are consistent with
earlier findings that indicate that community members may prefer
to prioritize child health [3,13,14].
These findings are also consistent with the ACIP’s recommen-
dations in July of 2009 which stated that children and young adults
aged 6 months–25 years should be among those prioritized for
pH1N1 vaccination, and that children 6 month–4 years should be
one of the groups prioritized under a scenario of limited vaccine
supply [1]. These recommendations were made based on data of
disease prevalence and risk of complications, and some limited
data from community engagement exercises performed as part of
pandemic preparedness [15]. Also considering these new prefer-
ence data obtained from community members after the recent
pH1N1 influenza pandemic may help policy makers better define
key target groups to prioritize for vaccination during the next
influenza pandemic.
Our analysis also indicates that certain characteristics of
community members may be significant predictors of health state
valuations. In adjusted analyses, we found that respondents with
less than a bachelor’s degree were willing to trade significantly
more time than those with a higher level of education to avoid all
four health states, controlling for other variables in a multivariate
regression. This finding is not consistent with values elicited for
seasonal influenza, and may represent a finding that is important
to note in light of the novel nature of pH1N1 compared to
seasonal influenza [3]. Hispanic and black, non-Hispanic
respondents were also willing to trade significantly more time
than white respondents to avoid uncomplicated pH1N1 illness and
severe allergic reaction. This statistical association between
respondent race and health state valuation is consistent with
values elicited from community members for seasonal influenza
and other health states [3,16]. Although no consensus exists
regarding the cause of the association, one possible explanation is
Table 2. Respondent influenza-related characteristics (n=659).
Frequency
Characteristic Unweighted Weighted
1
Received pH1N1 Vaccine in past 12 months 20.8% 19.8%
Received Seasonal Influenza Vaccine in past 12 months 41.7% 40.2%
Influenza Illness, Summary
Experienced pH1N1 Influenza Illness, Self 3.2% 4.3%
Experienced pH1N1 Influenza Illness, Family Member 5.3% 5.3%
Experienced Seasonal Influenza Illness, Self 31.2% 32.3%
Experienced Seasonal Influenza Illness, Family Member 17.5% 17.7%
Influenza-Related Hospitalization, Summary
Experienced pH1N1-Related Hospitalization, Self 0.2% 0.1%
Experienced pH1N1-Related Hospitalization, Family member 1.8% 1.8%
Experienced Seasonal Influenza-Related Hospitalization, Self 0.8% 1.3%
Experienced Seasonal Influenza-Related Hospitalization, Family Member 2.6% 3.0%
Vaccine-related Severe Allergic Reaction, Summary
Experienced Severe Allergic Reaction to pH1N1 vaccine, Self 0.5% 0.5%
Experienced Severe Allergic Reaction to pH1N1 vaccine, Family Member 0.2% 0.1%
Experienced Severe Allergic Reaction to Seasonal Influenza vaccine, Self 1.4% 1.5%
Experienced Severe Allergic Reaction to Seasonal Influenza vaccine, Family Member 1.2% 1.2%
Vaccine-related Guillain-Barre ´ Syndrome, Summary
Experienced pH1N1 Guillain-Barre ´ Syndrome, Self 0.3% 0.4%
Experienced pH1N1 Guillain-Barre ´ Syndrome, Family Member 0.0% 0.0%
Experienced Seasonal Influenza Guillain-Barre ´ Syndrome, Self 0.2% 0.2%
Experienced Seasonal Influenza Guillain-Barre ´ Syndrome, Family Member 0.3% 0.6%
1Post stratification weights were provided by Knowledge Networks to account for sampling and non-response bias.
doi:10.1371/journal.pone.0027777.t002
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e27777that respondents without a usual source of care may demonstrate a
stronger preference to avoid illness. Previous research has shown
that compared to white individuals, Hispanic and black individuals
are less likely to have a doctor’s office as their usual source of care,
regardless of insurance coverage, family income and geographic
region [17,18]. As we did not measure usual source of care, it is
possible that this variable confounded the race association found in
our analysis. Future research should assess respondents’ usual
source of care and parse out its contribution, along with race and
other factors, to health state preferences.
An important limitation of this study is that we used a stated
preference approach to value health states. These stated
preferences may not reflect the actual choices that these
respondents may make when faced with a choice between
accepting or rejecting vaccination. In addition, we used the
TTO approach for valuing health states, but other methods may
have produced different results [19]. As with most vignettes used to
estimate preferences, the scenarios used in our survey were concise
descriptions of complex health events; adding additional dimen-
sions of health to these vignettes may have influenced respondents’
valuations [20].
We also do not know the generalizability of these results. Our
measurement of public values for health states related only to this
influenza pandemic, and may not relate to more severe influenza
pandemics. Another limitation is that both the timing of our
survey and the representativeness of the sample may not have been
optimal for determining truly representative public values. The
survey was fielded after the fall epidemic had passed and the
vaccination program had been initiated, and so may not reflect the
important public values that were relevant during the time that
vaccination program decisions were being made. Data have shown
that the public’s concern about getting sick from pH1N1 as well as
their concern about the safety risks associated with vaccination
declined over the duration of the epidemic [21]. Also, compared to
non-respondents, our respondents were more likely to be college
educated, married, white, older males, and thus may have
reported values different from a more population representative
sample.
In this study we measured values for health outcomes related to
pH1N1 illness and vaccination from the general U.S. public, and
not specifically from those that have experienced pH1N1 illness.
Previous studies have found that compared to a sample of persons
Table 4. Loss in quality adjusted life years (QALYs) for 2009 pandemic influenza (A) H1N1 illness and vaccination-related adverse
events
1.
95% CI
2 Percentile Range
Loss in QALYs n Mean
Lower
bound
Upper
bound Median p-value
3 5
th 95
th min – max
Uncomplicated pH1N1 illness
1-year old 296 0.0394 0.0251 0.0625 0.0001 0 0.1708 0 – 1.0000
8-year old 345 0.0218 0.0132 0.0377 0.0001 0 0.0907 0 – 1.0000
35-year old 349 0.0138 0.0085 0.0247 0.0000 0 0.0551 0 – 1.0000
70-year old 307 0.0092 0.0059 0.0159 0.0001 0 0.0427 0 – 0.5226
All ages 1297 0.0207 0.0156 0.0267 0.0001 0.0211 0 0.0802 0 – 1.0000
pH1N1 illness-related hospitalization
1-year old 297 0.0391 0.0266 0.0613 0.0007 0 0.1851 0 – 1.0000
8-year old 342 0.0304 0.0200 0.0477 0.0006 0 0.1174 0 – 1.0000
35-year old 358 0.0217 0.0140 0.0362 0.0003 0 0.1125 0 – 1.0000
70-year old 307 0.0104 0.0073 0.0160 0.0003 0 0.0496 0 – 0.4034
All ages 1304 0.0253 0.0202 0.0320 0.0004 0.0005 0 0.1118 0 – 1.0000
Severe allergic reaction
1-year old 291 0.0317 0.0195 0.0536 0.0003 0 0.0853 0 – 1.0000
8-year old 341 0.0251 0.0162 0.0401 0.0003 0 0.1017 0 – 1.0000
35-year old 352 0.0166 0.0092 0.0325 0.0001 0 0.0496 0 – 1.0000
70-year old 301 0.0074 0.0051 0.0114 0.0001 0 0.0366 0 – 0.2183
All ages 1285 0.0201 0.0156 0.0266 0.0002 0.0002 0 0.0691 0 – 1.0000
Guillain-Barre ´ Syndrome
1-year old 292 0.0475 0.0329 0.0692 0.0039 0 0.1533 0 – 1.0000
8-year old 340 0.0391 0.0281 0.0584 0.0034 0 0.1381 0 – 1.0000
35-year old 351 0.0300 0.0204 0.0460 0.0012 0 0.1300 0 – 1.0000
70-year old 303 0.0135 0.0103 0.0194 0.0012 0 0.0640 0 – 0.4433
All ages 1286 0.0325 0.0268 0.0403 0.0019 0.0001 0 0.1236 0 – 1.0000
1Using unweighted data.
2To generate confidence intervals around our mean values, we used bootstrap re-sampling of size equal to the sample size (approximately 1300, depending on the
health state) with 3000 iterations. From each of the 3000 bootstrap samples generated, we calculate the overall means and means by scenario age to create a sampling
distribution around the original mean values.
3Kruskal-Wallis test evaluated whether median values differed by scenario age.
doi:10.1371/journal.pone.0027777.t004
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e27777who have not experienced an ill health state, those who have
experienced it are typically willing to trade less time to avoid the
illness [22,23,24]. Many of these studies, however, have focused on
chronic illnesses, and there is limited evidence as to how
experience or familiarity with a short term health state may
influence preferences for avoiding these health outcomes. Van
Hoek, et al. estimated a 0.008 QALY loss attributable to pH1N1
in a sample of confirmed pH1N1 cases using the EQ-5D
questionnaire. This QALY loss among those who have experi-
enced pH1N1 illness is difficult to compare to our results, however,
because it averages over a sample of confirmed cases with and
without complications [25]. In our adjusted analyses, we found
that those who experienced uncomplicated pH1N1 illness or
Guillain-Barre ´ syndrome were willing to trade significantly more
time to avoid these health states compared with those without
experience.(p-value,0.05 for both) More research is needed to
determine if such differences can be measured among other
experienced temporary health states.
Our findings suggest that the community-based values for
avoiding health events related to pH1N1 illness and vaccination
are consistent with the severity of the outcomes. These data also
suggest that the public places a greater value on preventing
outcomes in children, compared to adults, consistent with previous
findings from seasonal influenza. The valuations derived from
Table 5. Multivariate regression results: Time trade-off amounts by scenario age, sociodemographics, illness experience, and
vaccination status, predicted number of days traded.
Uncomplicated
pH1N1 Illness
1
pH1N1 Illness-related
Hospitalization
1
Severe Allergic
Reaction
1
Guillain-Barre ´
syndrome
1
Predictors Estimate SE Estimate SE Estimate SE Estimate SE
Scenario Age
1 year 212.06* 37.01 315.06* 58.43 179.30* 27.74 362.55* 37.06
8 years 133.87* 22.99 251.47* 38.29 178.54* 29.05 333.34* 31.00
35 years
# 88.78 14.85 181.07 30.35 102.06 16.23 242.78 25.73
70 years 82.08 14.85 122.77* 20.45 80.64 13.96 189.30* 18.70
Gender
Male 134.10 26.92 200.55 41.21 108.78 20.23 229.98 29.66
Female
# 104.70 17.07 208.23 32.77 148.69 27.87 322.87 41.48
Respondent Age
18–29 yrs
# 42.86 12.81 122.78 47.80 77.00 20.49 164.66 31.36
30–44 yrs 127.30* 43.66 262.50 85.75 123.10 44.75 321.42* 76.84
45–59 yrs 119.70* 29.61 215.97 52.96 143.05 35.93 277.05* 47.67
60 & above 207.41* 51.82 205.09 44.66 153.84 40.95 312.47* 54.33
Education
,High School 307.60* 112.78 271.93* 82.06 197.52* 55.70 328.23* 68.15
High School 231.97* 55.77 322.30* 69.34 295.44* 77.68 512.44* 97.07
Some College 159.83* 34.98 266.07* 75.05 125.63* 30.76 239.68* 44.32
Bachelors & above
# 37.24 10.28 84.92 22.89 40.57 10.34 139.32 19.30
Race/Ethnicity
White, Non- Hispanic
# 100.84 16.67 179.64 28.27 102.87 16.67 248.76 25.90
Black, Non- Hispanic 538.04* 192.98 456.50 206.98 299.25* 87.53 406.62 125.60
Other, Non- Hispanic 55.84 27.92 143.50 65.01 113.87 39.06 246.96 133.04
Hispanic 383.92* 109.84 342.61 125.27 342.63* 117.27 421.06 132.49
Children ,18 yrs
No
# 144.92 29.99 216.02 42.25 132.97 26.97 244.80 32.11
Yes 98.31 21.74 182.12 44.81 116.23 24.89 340.97 62.31
Experience with Illness (self/family)
No
# 78.28 12.19 201.51 26.82 125.72 17.08 271.10 24.55
Yes 236.97* 54.85 298.85 144.91 221.94 106.39 1234.26* 688.48
pH1N1 Vaccination Status
No
# 115.07 17.92 177.67 27.00 108.86 16.52 242.64 24.51
Yes 189.87 46.87 347.31* 90.24 231.03* 64.04 425.03* 92.75
*p-value,0.05; indicates statistical difference of value compared to the reference group.
#Reference group.
1Model goodness-of-fit concordance coefficients and confidence intervals- uncomplicated pH1N1 illness: 0.129 (95% CI:0.090, 0.168), pH1N1 illness-related
hospitalization: 0.071 (95% CI: 0.051,0.092), Severe Allergic Reaction: 0.095 (95% CI: 0.071,0.118), Guillain-Barre ´ syndrome: 0.112 (95% CI: 0.089,0.135).
doi:10.1371/journal.pone.0027777.t005
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e27777these data can be used along with other decision-making factors
during the development of pandemic influenza vaccination
programs in the U.S. and the allocation of future pandemic
vaccine supplies.
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